Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 9, 2004, Pages 643-648

  Thajeb, Peterus ^a,b,c   Thajeb, Teguh ^d   Dai, Daofu ^e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d LI SHIN HOSPITAL   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; KETOCONAZOLE;

ADULT; ANEURYSM RUPTURE; ARTICLE; BASILAR ARTERY; BRAIN INFARCTION; CAROTID ARTERY; CASE REPORT; CAUSE OF DEATH; CAVERNOUS SINUS THROMBOSIS; CEREBROVASCULAR DISEASE; CRANIOTOMY; DEBRIDEMENT; DECOMPRESSION SURGERY; DIABETIC ANGIOPATHY; EVISCERATION; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; KETOACIDOSIS; MALE; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORBIT CELLULITIS; PARANASAL SINUS; RHINOORBITOCEREBRAL MUCORMYCOSIS; STROKE; SUBARACHNOID HEMORRHAGE;

AGED; ANTIFUNGAL AGENTS; BIOPSY, NEEDLE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUCORMYCOSIS; NOSE DISEASES; ORBITAL DISEASES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TAIWAN; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 4644308719     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020794     Document Type: Article

References (36)

1. Paultauf A. Mycosis mucorina: Ein Beitrag zur kenntniss der menschlichen fadenpilzer krankugen. Virchows Arch Pathol Anat 1885; 102: 543-64.
2. Gregory JE, Golden A, Haymaker W. Mucormycosis of the central nervous system. A report of 3 cases. Bull Johns Hopkins Hosp 1943; 73: 403-19.
3. Baker RD. Mucormycosis: a new disease? JAMA 1957; 163: 805-8.
4. Rangel-Guerra R, Martinez HR, Saenz C. Mucormycosis: report of 11 cases. Arch Neurol 1985; 42: 578-81.
5. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001; 44: 253-60.
6. Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14(Suppl 1): 126-9.
7. Galetta SL, Wulc AE, Goldberg HI, Nichols CW, Glaser JS. Rhinocerebral mucormycosis: management and survival after carotid occlusion. Ann Neurol 1990; 28: 103-7.
8. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with hematological malignancies: a retrospective clinical study of 37 cases. Br J Haematol 1977; 99: 331-6.
9. Mathur SC, Friedman HD, Kende AI, Davis RI, Graziano SL. Cryptic Mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy. Ann Haematol 1999; 78: 241-5.
10. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: 3 case reports and review. Clin Infect Dis 1994; 19: 1133-7.
11. Boelaert JR, Fenves AZ, Coburn JW. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis 1991; 18: 660-7.
12. Anaissie EJ, Shikhani AH. Rhinocerebral mucormycosis with internal carotid occlusion: report of 2 cases and review of the literature. Laryngoscope 1985; 95: 1107-13.
13. Abedi E, Sismanis A, Choi K, Pastore P. 25 y experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984; 94: 1060-2.
14. Calli C, Savas R, Parildar M, Pekindil G, Alper H, Yunten N. Isolated pontine infarction due to rhinocerebral mucormycosis. Neuroradiology 1999; 41: 179-81.
15. Hussain S, Salahuddin N, Ahmad I, Salahuddin I, Jooma R. Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. Eur J Rad 1995; 20: 151-5.
16. Mauriello JA Jr, Yepez N, Mostafavi R, Barofsky J, Kapila R, Baredes S, et al. Invasive rhinosino-orbital aspergillosis with precipitous visual loss. Can J Ophthalmol 1995; 30: 124-30.
17. deShazo RD, O'Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 1997; 123: 1181-8.
18. Ciesla MC, Kammeyer PL, Yeldandi V, Petruzzelli GJ, Yong SL. Identification of the asexual state of Rhizopus species on histologic tissue sections in a patient with rhinocerebral mucormycosis. Arch Pathol Lab Med 2000; 124: 883-7.
19. O'Brien TJ, McKelvie P. Rhinocerebral mucormycosis presenting as periorbital cellulitis with blindness: report of 2 cases. Clin Exp Neurol 1994; 31: 68-78.
20. Sponsler TA, Sassani JW, Johnson LN, Towfighi J. Ocular invasion in mucormycosis. Clinical pathological review. Survey Ophthalmol 1992; 36: 345-50.
21. Chimelli L, Mahler-Araujo MB. Fungal infections. Brain Pathol 1997; 7: 613-27.
22. McLean FM, Ginsberg LE, Stanton CA. Perineural spread of rhinocerebral mucormycosis. AJNR 1996; 17: 114-6.
23. Sheldon WH, Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med 1959; 110: 845-52.
24. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984; 74: 150-60.
25. Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997; 107: 855-62.
26. Scully RE, Mark EJ, McNeely WF, Ebeling SH, Phillips LD, Ellender SM. Case records of the Massachusetts General Hospital. Case 22-1999. A 68-y-old female with multiple myeloma, diabetes mellitus, and an inflamed eye. N Engl J Med 1999; 341: 265-73.
27. Vazquez JA, Sobel JD. Fungal infections in diabetes. Infectious Disease Clinics of North America 1995; 9: 97-116.
28. Parfrey NA. Improved diagnosis and prognosis of mucormycosis: a clinicopathologic study of 33 cases. Medicine 1986; 65: 113-23.
29. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980; 90: 635.
30. Yohai RA, Bulock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Survey Ophthalmol 1994; 39: 3-22.
31. Keane JR. Cavernous sinus syndrome: analysis of 151 cases. Arch Neurol 1996; 53: 967-71.
32. Kohn R, Hepler R. Management of limited rhino-orbital mucormycosis without exenteration. Ophthalmology 1985; 92: 1440-4.
33. Eucker J, Sezer O, Lehmann R, Weber JR, Graf B, Denkert C, et al. Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis. Infection 2000; 28: 246-50.
34. Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin Br J Laryngol Otol 1991; 105: 575-7.
35. Moses AE, Rahav G, Barenholz Y, Elidan J, Azaz B, Gillis S, et al. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in 3 patients. Clin Infectious Dis 1998; 26: 1430-3.
36. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980; 90: 737-47.